The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older. This is the first FDA-approved drug that contains a purified drug substance derived from marijuana. It is also the first FDA approval of a drug for the treatment of patients with Dravet syndrome.
University of Toronto researchers have developed a handheld 3D skin printer that deposits even layers of skin tissue to cover and heal deep wounds. The team believes it to be the first device that forms tissue in situ, depositing and setting in place, within two minutes or less.
Vladimir Putin is planning a roughly 10 trillion-ruble ($162 billion) increase in spending on health care, education and infrastructure, hoping to kick-start sputtering economic growth in his new presidential term, according to people familiar with the plans.
The advanced research Foundation (DRF) has established a laboratory to identify the likely directions of technological breakthroughs in the military field on the basis of Institute of immunology, reported RIA Novosti in the Fund.
The U.S. Food and Drug Administration today permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes.
U.S. Secretary of Agriculture Sonny Perdue today issued a statement providing clarification on the U.S. Department of Agriculture’s (USDA) oversight of plants produced through innovative new breeding techniques which include techniques called genome editing.
A new study out today in the journal JAMA Neurology shows that smartphone software and technology can accurately track the severity of the symptoms of Parkinson’s disease. The findings could provide researchers and clinicians with a new tool to both develop new drugs and better treat this challenging disease.